Subsequently, we tested the impact of MEK, ERK and AKT inhibition in these NSCLC cell lines and observed that KRASG12C lines were more sensitive to ERK or MEK inhibition, while KRASG12D lines were more sensitive to AKT inhibition (Fig. 4G and Supplementary Figure S6C). Here, MAP2K7 is linked to non-small cell lung carcinoma.